These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis. Loilome W; Wechagama P; Namwat N; Jusakul A; Sripa B; Miwa M; Kuver R; Yongvanit P Parasitol Int; 2012 Mar; 61(1):136-9. PubMed ID: 21763455 [TBL] [Abstract][Full Text] [Related]
4. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis. Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma. Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. Chusorn P; Namwat N; Loilome W; Techasen A; Pairojkul C; Khuntikeo N; Dechakhamphu A; Talabnin C; Chan-On W; Ong CK; Teh BT; Yongvanit P Tumour Biol; 2013 Jun; 34(3):1579-88. PubMed ID: 23417858 [TBL] [Abstract][Full Text] [Related]
8. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma. Yongvanit P; Pinlaor S; Loilome W J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859 [TBL] [Abstract][Full Text] [Related]
9. Serum antibody response to Opisthorchis viverrini antigen as a marker for opisthorchiasis-associated cholangiocarcinoma. Akai PS; Pungpak S; Chaicumpa W; Viroj K; Bunnag D; Befus AD Trans R Soc Trop Med Hyg; 1994; 88(4):471-4. PubMed ID: 7570848 [TBL] [Abstract][Full Text] [Related]
10. Mutations of KRAS and TP53 in a minor proportion of Opisthorchis viverrini-associated cholangiocarcinomas in a hamster model. Tangkawattana S; Kaewkes S; Pairojkul C; Tangkawattana P; Sripa B Asian Pac J Cancer Prev; 2008; 9(1):101-6. PubMed ID: 18439086 [TBL] [Abstract][Full Text] [Related]
11. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954 [No Abstract] [Full Text] [Related]
12. Plasma phosphoproteome and differential plasma phosphoproteins with opisthorchis viverrini-related cholangiocarcinoma. Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K Asian Pac J Cancer Prev; 2015; 16(3):1011-8. PubMed ID: 25735322 [TBL] [Abstract][Full Text] [Related]
13. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma. Wang LJ; Zhang KL; Zhang N; Ma XW; Yan SW; Cao DH; Shi SJ Oncotarget; 2015 Jul; 6(21):18631-40. PubMed ID: 26087181 [TBL] [Abstract][Full Text] [Related]